ARGX:NSD-argenx NV ADR (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 515.87

Change

+6.66 (+1.31)%

Market Cap

USD 30.45B

Volume

0.42M

Analyst Target

USD 254.56
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-31 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
REGN Regeneron Pharmaceuticals Inc

N/A

USD 130.01B
VRTX Vertex Pharmaceuticals Inc

N/A

USD 123.52B
ALNY Alnylam Pharmaceuticals Inc

N/A

USD 32.27B
MRNA Moderna Inc

N/A

USD 28.23B
BGNE BeiGene Ltd

N/A

USD 20.54B
BMRN Biomarin Pharmaceutical Inc

N/A

USD 17.44B
RPRX Royalty Pharma Plc

N/A

USD 17.14B
UTHR United Therapeutics Corporatio..

N/A

USD 15.72B
INSM Insmed Inc

N/A

USD 12.93B
SRPT Sarepta Therapeutics Inc

N/A

USD 12.85B

ETFs Containing ARGX

IBRN iShares Trust - iShares N.. 4.95 % 0.00 %

N/A

USD 3.84M
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.14 % 0.00 %

N/A

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.14 % 0.00 %

N/A

N/A
HEAL:SW iShares Healthcare Innova.. 1.96 % 0.00 %

N/A

N/A
STWX:SW SPDR® MSCI Europe Health.. 1.64 % 0.00 %

N/A

USD 0.83B
ESIH:XETRA iShares MSCI Europe Healt.. 1.64 % 0.00 %

N/A

USD 0.60B
TEET:LSE VanEck Sustainable Europe.. 1.36 % 0.00 %

N/A

USD 0.05B
TEET:SW VanEck Sustainable Europe.. 1.36 % 0.00 %

N/A

USD 0.05B
TEGB:LSE VanEck Sustainable Europe.. 1.25 % 0.00 %

N/A

N/A
AGED:SW iShares Ageing Population.. 0.61 % 0.00 %

N/A

N/A
TSWE:SW VanEck Sustainable World .. 0.54 % 0.00 %

N/A

USD 0.73B
TSGB:LSE VanEck Sustainable World .. 0.54 % 0.00 %

N/A

USD 0.75B
TSWE:LSE VanEck Sustainable World .. 0.49 % 0.00 %

N/A

N/A
BBH VanEck Biotech ETF 0.00 % 0.35 %

N/A

USD 0.45B
FBT First Trust NYSE Arca Bio.. 0.00 % 0.57 %

N/A

N/A
AGED:LSE iShares Ageing Population.. 0.00 % 0.00 %

N/A

N/A
AGES:LSE iShares IV Public Limited.. 0.00 % 0.00 %

N/A

N/A
DRDR:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

N/A
HEAL:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

N/A
HLTH:LSE SPDR® MSCI Europe Health.. 0.00 % 0.00 %

N/A

N/A
XSDR:LSE Xtrackers MSCI Europe Hea.. 0.00 % 0.00 %

N/A

USD 0.21B
STW:PA SPDR® MSCI Europe Health.. 0.00 % 0.00 %

N/A

USD 0.84B
DXSE:F Xtrackers Stoxx Europe 60.. 0.00 % 0.00 %

N/A

N/A
EXV4:F iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

N/A
SPYH:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

N/A
TSWE:F VanEck Sustainable World .. 0.00 % 0.00 %

N/A

USD 0.72B
V3ET:F VanEck Vectors ETFs N.V. .. 0.00 % 0.00 %

N/A

USD 0.05B
2B77:XETRA iShares Ageing Population.. 0.00 % 0.00 %

N/A

USD 0.50B
2B78:XETRA iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

USD 1.14B
DXSE:XETRA Xtrackers - Stoxx Europe .. 0.00 % 0.00 %

N/A

USD 0.14B
EXV4:XETRA iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

USD 0.70B
SPYH:XETRA SPDR® MSCI Europe Health.. 0.00 % 0.00 %

N/A

USD 0.66B
TSWE:XETRA VanEck Sustainable World .. 0.00 % 0.00 %

N/A

USD 0.72B
V3ET:XETRA VanEck Sustainable Europe.. 0.00 % 0.00 %

N/A

USD 0.05B
BMED BlackRock Future Health E.. 0.00 % 0.00 %

N/A

USD 4.21M
2B77:F iShares Ageing Population.. 0.00 % 0.00 %

N/A

N/A
2B78:F iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

N/A
ESIH:LSE iShares MSCI Europe Healt.. 0.00 % 0.00 %

N/A

USD 0.70B
ESIH:F Ishares VI PLC - Ishares .. 0.00 % 0.00 %

N/A

USD 0.63B
HEAE:LSE SPDR® MSCI Europe Health.. 0.00 % 0.00 %

N/A

N/A
SXDPEX:SW iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

USD 0.44B

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 35.85% 79% B- 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 35.85% 79% B- 88% B+
Trailing 12 Months  
Capital Gain 3.14% 65% D 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.14% 65% D 50% F
Trailing 5 Years  
Capital Gain 261.73% 93% A 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 261.73% 93% A 93% A
Average Annual (5 Year Horizon)  
Capital Gain 34.07% 82% B 87% B+
Dividend Return 34.07% 82% B 86% B+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 38.44% 71% C- 47% F
Risk Adjusted Return 88.64% 99% N/A 94% A
Market Capitalization 30.45B 99% N/A 97% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector